Molecular imaging of cell-mediated cancer immunotherapy

被引:34
|
作者
Lucignani, Giovanni
Ottobrini, Luisa
Martelli, Cristina
Rescigno, Maria
Clerici, Mario
机构
[1] Univ Milan, Inst Radiol Sci, I-20142 Milan, Italy
[2] European Inst Oncol, Unit Mol Imaging, Div Radiat Therapy, I-20141 Milan, Italy
[3] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[4] Univ Milan, Osped L Sacco, Padigl LITA, I-20154 Milan, Italy
关键词
D O I
10.1016/j.tibtech.2006.07.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
New strategies based on the activation of a patient's immune response are being sought to complement present conventional exogenous cancer therapies. Elucidating the trafficking pathways of immune cells in vivo, together with their migratory properties in relation to their differentiation and activation status, is useful for understanding how the immune system interacts with cancer. Methods based on tissue sampling to monitor immune responses are inadequate for repeatedly characterizing the responses of the immune system in different organs. A solution to this problem might come from molecular and cellular imaging - a branch of biomedical sciences that combines biotechnology and imaging methods to characterize, in vivo, the molecular and cellular processes involved in normal and pathologic states. The general concepts of noninvasive imaging of targeted cells as well as the technology and probes applied to cell-mediated cancer immunotherapy imaging are outlined in this review.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 50 条
  • [1] STRATEGIES FOR CELL-MEDIATED IMMUNOTHERAPY OF CANCER - KILLING OR HELP
    FORNI, G
    GIOVARELLI, M
    IMMUNOLOGY TODAY, 1986, 7 (7-8): : 202 - 203
  • [2] Nanobodies in cell-mediated immunotherapy: On the road to fight cancer
    Maali, Amirhosein
    Gholizadeh, Monireh
    Feghhi-Najafabadi, Saba
    Noei, Ahmad
    Seyed-Motahari, Seyedeh Sheila
    Mansoori, Shafieeh
    Sharifzadeh, Zahra
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Biomaterials Facilitating Dendritic Cell-Mediated Cancer Immunotherapy
    Dong, Heng
    Li, Qiang
    Zhang, Yu
    Ding, Meng
    Teng, Zhaogang
    Mou, Yongbin
    ADVANCED SCIENCE, 2023, 10 (18)
  • [4] Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer
    Mustafa, Mujahed I.
    Mohammed, Ahmed
    SLAS DISCOVERY, 2023, 28 (08) : 358 - 364
  • [5] A novel cell-mediated immunotherapy for treatment of lung and breast cancer
    Venugopal, Indu
    Gormley, Claire
    McGuire, Michael J.
    Brown, Kathlynn C.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [6] microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy
    Daveri, Elena
    Vergani, Elisabetta
    Shahaj, Eriomina
    Bergamaschi, Laura
    La Magra, Stefano
    Dosi, Michela
    Castelli, Chiara
    Rodolfo, Monica
    Rivoltini, Licia
    Vallacchi, Viviana
    Huber, Veronica
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] Personalized T cell-mediated cancer immunotherapy: progress and challenges
    Bethune, Michael T.
    Joglekar, Alok V.
    CURRENT OPINION IN BIOTECHNOLOGY, 2017, 48 : 142 - 152
  • [8] CELL-MEDIATED CYTOTOXICITY AND IMMUNOTHERAPY CHEMOTHERAPY IN CANCER-TREATMENT
    DEFILIPPI, R
    BONFINI, TD
    RICCI, F
    NUNZIATA, C
    FUGGETTA, MP
    SCARSI, A
    DEVECCHIS, L
    BONMASSAR, E
    MICROBIOLOGICAL, CHEMOTHERAPEUTICAL AND IMMUNOLOGICAL PROBLEMS IN HIGH RISK PATIENTS, 1989, 61 : 55 - 62
  • [9] Putting the brakes on BTLA in T cell-mediated cancer immunotherapy
    Paulos, Chrystal M.
    June, Carl H.
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (01): : 76 - 80
  • [10] Dendritic cell-mediated cancer immunotherapy with Ecklonia cava fucoidan
    Park, Hae-Bin
    Hwang, Juyoung
    Lim, Seong-Min
    Zhang, Wei
    Jin, Jun-O
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 159 : 941 - 947